Henry Bourang

Advanced Bifurication Systems, Inc. develops novel technology to enable stenting of coronary arteries. Its platform offers clinical case demonstrations, first human trial, and intellectual property. The company was founded by Henry Bourang and Mehran J. Khorsandi in 2008 and is headquartered in Los Angeles, CA.

Advanced Bifurication Systems, Inc. develops novel technology to enable stenting of coronary arteries. Its platform offers clinical case demonstrations, first human trial, and intellectual property. The company was founded by Henry Bourang and Mehran J. Khorsandi in 2008 and is headquartered in Los Angeles, CA.

Advanced Bifurication Systems, Inc. develops novel technology to enable stenting of coronary arteries. Its platform offers clinical case demonstrations, first human trial, and intellectual property. The company was founded by Henry Bourang and Mehran J. Khorsandi in 2008 and is headquartered in Los Angeles, CA.

Advanced Bifurication Systems, Inc. develops novel technology to enable stenting of coronary arteries. Its platform offers clinical case demonstrations, first human trial, and intellectual property. The company was founded by Henry Bourang and Mehran J. Khorsandi in 2008 and is headquartered in Los Angeles, CA.

Advanced Bifurication Systems, Inc. develops novel technology to enable stenting of coronary arteries. Its platform offers clinical case demonstrations, first human trial, and intellectual property. The company was founded by Henry Bourang and Mehran J. Khorsandi in 2008 and is headquartered in Los Angeles, CA.